Single User License
INR 101235
Site License
INR 202470
Corporate User License
INR 303705

Service Tax Additional

select a format
Price

Single User License
USD 1500
Site License
USD 3000
Corporate User License
USD 4500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Les Laboratoires Servier SAS-Product Pipeline Review-2015

Les Laboratoires Servier SAS-Product Pipeline Review-2015


  Request for Sample Report

Executive Summary

Les Laboratoires Servier SAS-Product Pipeline Review-2015

Summary

Global Markets Direct's, 'Les Laboratoires Servier SAS-Product Pipeline Review-2015', provides an overview of the Les Laboratoires Servier SAS's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Les Laboratoires Servier SAS's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides brief overview of Les Laboratoires Servier SAS including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Les Laboratoires Servier SAS's human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the Les Laboratoires Servier SAS's pipeline products

Reasons To Buy

Evaluate Les Laboratoires Servier SAS's strategic position with total access to detailed information on its product pipeline

Assess the growth potential of Les Laboratoires Servier SAS in its therapy areas of focus

Identify new drug targets and therapeutic classes in the Les Laboratoires Servier SAS's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of Les Laboratoires Servier SAS and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of Les Laboratoires Servier SAS

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of Les Laboratoires Servier SAS and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Les Laboratoires Servier SAS Snapshot 6

Les Laboratoires Servier SAS Overview 6

Key Information 6

Key Facts 6

Les Laboratoires Servier SAS-Research and Development Overview 7

Key Therapeutic Areas 7

Les Laboratoires Servier SAS-Pipeline Review 10

Pipeline Products by Stage of Development 10

Pipeline Products-Monotherapy 11

Pipeline Products-Combination Treatment Modalities 12

Pipeline Products-Partnered Products 13

Partnered Products/Combination Treatment Modalities 14

Les Laboratoires Servier SAS-Pipeline Products Glance 16

Les Laboratoires Servier SAS-Late Stage Pipeline Products 16

Pre-Registration Products/Combination Treatment Modalities 16

Phase III Products/Combination Treatment Modalities 17

Les Laboratoires Servier SAS-Clinical Stage Pipeline Products 18

Phase II Products/Combination Treatment Modalities 18

Phase I Products/Combination Treatment Modalities 19

Les Laboratoires Servier SAS-Early Stage Pipeline Products 20

Preclinical Products/Combination Treatment Modalities 20

Discovery Products/Combination Treatment Modalities 21

Les Laboratoires Servier SAS-Drug Profiles 22

(perindopril + amlodipine besylate) 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

gevokizumab 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

ivabradine 26

Product Description 26

Mechanism of Action 26

R&D Progress 26

lucitanib 27

Product Description 27

Mechanism of Action 27

R&D Progress 27

S-38844 29

Product Description 29

Mechanism of Action 29

R&D Progress 29

S-47445 30

Product Description 30

Mechanism of Action 30

R&D Progress 30

S-49076 32

Product Description 32

Mechanism of Action 32

R&D Progress 32

S-055746 33

Product Description 33

Mechanism of Action 33

R&D Progress 33

Small Molecule to Inhibit Mcl-1 for Cancer 34

Product Description 34

Mechanism of Action 34

R&D Progress 34

Drugs to Inhibit Insulin-Regulated AminoPeptidase for Alzheimer's Disease 35

Product Description 35

Mechanism of Action 35

R&D Progress 35

Monoclonal Antibodies for Cancer 36

Product Description 36

Mechanism of Action 36

R&D Progress 36

Drugs for Breast Cancer 37

Product Description 37

Mechanism of Action 37

R&D Progress 37

Les Laboratoires Servier SAS-Pipeline Analysis 38

Les Laboratoires Servier SAS-Pipeline Products by Target 38

Les Laboratoires Servier SAS-Pipeline Products by Route of Administration 40

Les Laboratoires Servier SAS-Pipeline Products by Molecule Type 41

Les Laboratoires Servier SAS-Pipeline Products by Mechanism of Action 42

Les Laboratoires Servier SAS-Recent Pipeline Updates 44

Les Laboratoires Servier SAS-Dormant Projects 54

Les Laboratoires Servier SAS-Discontinued Pipeline Products 55

Discontinued Pipeline Product Profiles 55

agomelatine 55

terutroban 55

Les Laboratoires Servier SAS-Company Statement 56

Les Laboratoires Servier SAS-Locations And Subsidiaries 57

Head Office 57

Other Locations & Subsidiaries 57

Appendix 61

Methodology 61

Coverage 61

Secondary Research 61

Primary Research 61

Expert Panel Validation 61

Contact Us 61

Disclaimer 62

List of Tables

Les Laboratoires Servier SAS, Key Information 6

Les Laboratoires Servier SAS, Key Facts 6

Les Laboratoires Servier SAS-Pipeline by Indication, 2015 8

Les Laboratoires Servier SAS-Pipeline by Stage of Development, 2015 10

Les Laboratoires Servier SAS-Monotherapy Products in Pipeline, 2015 11

Les Laboratoires Servier SAS-Combination Treatment Modalities in Pipeline, 2015 12

Les Laboratoires Servier SAS-Partnered Products in Pipeline, 2015 13

Les Laboratoires Servier SAS-Partnered Products/ Combination Treatment Modalities, 2015 14

Les Laboratoires Servier SAS-Pre-Registration, 2015 16

Les Laboratoires Servier SAS-Phase III, 2015 17

Les Laboratoires Servier SAS-Phase II, 2015 18

Les Laboratoires Servier SAS-Phase I, 2015 19

Les Laboratoires Servier SAS-Preclinical, 2015 20

Les Laboratoires Servier SAS-Discovery, 2015 21

Les Laboratoires Servier SAS-Pipeline by Target, 2015 39

Les Laboratoires Servier SAS-Pipeline by Route of Administration, 2015 40

Les Laboratoires Servier SAS-Pipeline by Molecule Type, 2015 41

Les Laboratoires Servier SAS-Pipeline Products by Mechanism of Action, 2015 43

Les Laboratoires Servier SAS-Recent Pipeline Updates, 2015 44

Les Laboratoires Servier SAS-Dormant Developmental Projects,2015 54

Les Laboratoires Servier SAS-Discontinued Pipeline Products, 2015 55

Les Laboratoires Servier SAS, Other Locations 57

Les Laboratoires Servier SAS, Subsidiaries 58

List of Figures

Les Laboratoires Servier SAS-Pipeline by Top 10 Indication, 2015 8

Les Laboratoires Servier SAS-Pipeline by Stage of Development, 2015 10

Les Laboratoires Servier SAS-Monotherapy Products in Pipeline, 2015 11

Les Laboratoires Servier SAS-Partnered Products in Pipeline, 2015 13

Les Laboratoires Servier SAS-Pipeline by Top 10 Target, 2015 38

Les Laboratoires Servier SAS-Pipeline by Top 10 Route of Administration, 2015 40

Les Laboratoires Servier SAS-Pipeline by Top 10 Molecule Type, 2015 41

Les Laboratoires Servier SAS-Pipeline Products by Top 10 Mechanism of Action, 2015 42

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Current R&D Portfolio of Les Laboratoires Servier SAS; Les Laboratoires Servier SAS - Key Therapeutics; Les Laboratoires Servier SAS - Pipeline Overview and Promising Molecules; Les Laboratoires Servier SAS - News; Les Laboratoires Servier SAS - Latest Updates; Les Laboratoires Servier SAS - Pipeline; Les Laboratoires Servier SAS - Discontinued/Dormant Projects


Related Products in vertical
Other reports by publisher
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com